Resources for Healthcare Investors

 

description here

The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.


Thematic Reports

Piper Sandler’s thematic BioInsights reports dive deep into a diverse array of disease pathways, indications of interest and novel therapeutic modalities. The reports explore current and emerging competitive landscapes and provide detailed profiles of key public and private players in each space – reviewing relevant pipeline and marketed assets, available clinical data and upcoming catalysts of interest.

 
32 141 22 25+
  Thematic reports   Pages per report*   Company profiles*   Topics covered

Report topics cover:

PSC
EMERGING THEMES IN BIOPHARMA
Artificial intelligence and machine learning, the evolution of generics and biosimilars
PSC
INNOVATIVE THERAPEUTIC MODALITIES AND TARGETS
Cell and gene therapies, engineered cytokines, RNA medicines, gene editing, drugging transcription factors, protein degradation, TGF-beta, and precision cardiovascular medicine
PSC
NOVEL STRATEGIES TO ADDRESS DISEASE INDICATIONS
Chronic hepatitis B, women’s and men’s health, cystic fibrosis, medical dermatology, oncology, pain, epilepsy, gastrointestinal disorders, psychiatry and mood disorders, renal disorders, movement disorders, and sickle cell disease
 

Catalyst Calendars

Our catalyst calendars include summaries of key biopharma events within the Piper Sandler coverage universe.

KOL Day Recaps

Key Opinion Leader day recaps provide detailed thoughts from panel discussions and key takeaways from industry leaders.

Conferences & Events

We bring together key industry executives and our own professionals to provide multiple perspectives, investigate critical trends, and identify the leaders in biopharma.

Learn More

Access market-driven and actionable insights.

Contact the BioInsights team or connect with our analysts for more information on available resources and with feedback or suggestions for future report topics or events of interest.

Access Now